Your browser doesn't support javascript.
loading
Reconstruction of ancient microbial genomes from the human gut.
Wibowo, Marsha C; Yang, Zhen; Borry, Maxime; Hübner, Alexander; Huang, Kun D; Tierney, Braden T; Zimmerman, Samuel; Barajas-Olmos, Francisco; Contreras-Cubas, Cecilia; García-Ortiz, Humberto; Martínez-Hernández, Angélica; Luber, Jacob M; Kirstahler, Philipp; Blohm, Tre; Smiley, Francis E; Arnold, Richard; Ballal, Sonia A; Pamp, Sünje Johanna; Russ, Julia; Maixner, Frank; Rota-Stabelli, Omar; Segata, Nicola; Reinhard, Karl; Orozco, Lorena; Warinner, Christina; Snow, Meradeth; LeBlanc, Steven; Kostic, Aleksandar D.
Afiliación
  • Wibowo MC; Section on Pathophysiology and Molecular Pharmacology, Joslin Diabetes Center, Boston, MA, USA.
  • Yang Z; Department of Microbiology, Harvard Medical School, Boston, MA, USA.
  • Borry M; Section on Pathophysiology and Molecular Pharmacology, Joslin Diabetes Center, Boston, MA, USA.
  • Hübner A; Department of Microbiology, Harvard Medical School, Boston, MA, USA.
  • Huang KD; Department of Combinatorics and Optimization, University of Waterloo, Waterloo, Ontario, Canada.
  • Tierney BT; Department of Archaeogenetics, Max Planck Institute for the Science of Human History, Jena, Germany.
  • Zimmerman S; Department of Archaeogenetics, Max Planck Institute for the Science of Human History, Jena, Germany.
  • Barajas-Olmos F; CIBIO Department, University of Trento, Trento, Italy.
  • Contreras-Cubas C; Research and Innovation Centre, Fondazione Edmund Mach, San Michele all'Adige, Italy.
  • García-Ortiz H; Section on Pathophysiology and Molecular Pharmacology, Joslin Diabetes Center, Boston, MA, USA.
  • Martínez-Hernández A; Department of Microbiology, Harvard Medical School, Boston, MA, USA.
  • Luber JM; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
  • Kirstahler P; Section on Pathophysiology and Molecular Pharmacology, Joslin Diabetes Center, Boston, MA, USA.
  • Blohm T; Department of Microbiology, Harvard Medical School, Boston, MA, USA.
  • Smiley FE; Immunogenomics and Metabolic Diseases Laboratory, Secretaría de Salud, Instituto Nacional de Medicina Genómica, Mexico City, Mexico.
  • Arnold R; Immunogenomics and Metabolic Diseases Laboratory, Secretaría de Salud, Instituto Nacional de Medicina Genómica, Mexico City, Mexico.
  • Ballal SA; Immunogenomics and Metabolic Diseases Laboratory, Secretaría de Salud, Instituto Nacional de Medicina Genómica, Mexico City, Mexico.
  • Pamp SJ; Immunogenomics and Metabolic Diseases Laboratory, Secretaría de Salud, Instituto Nacional de Medicina Genómica, Mexico City, Mexico.
  • Russ J; Section on Pathophysiology and Molecular Pharmacology, Joslin Diabetes Center, Boston, MA, USA.
  • Maixner F; Department of Microbiology, Harvard Medical School, Boston, MA, USA.
  • Rota-Stabelli O; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Segata N; Research Group for Genomic Epidemiology, National Food Institute, Technical University of Denmark, Kongens Lyngby, Denmark.
  • Reinhard K; Department of Anthropology, University of Montana, Missoula, MT, USA.
  • Orozco L; Department of Anthropology, Northern Arizona University, Flagstaff, AZ, USA.
  • Warinner C; Pahrump Paiute Tribe and Consolidated Group of Tribes and Organizations, Pahrump, NV, USA.
  • Snow M; Department of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA, USA.
  • LeBlanc S; Research Group for Genomic Epidemiology, National Food Institute, Technical University of Denmark, Kongens Lyngby, Denmark.
  • Kostic AD; Morrison Microscopy Core Research Facility, Center for Biotechnology, University of Nebraska-Lincoln, Lincoln, NE, USA.
Nature ; 594(7862): 234-239, 2021 06.
Article en En | MEDLINE | ID: mdl-33981035
Loss of gut microbial diversity1-6 in industrial populations is associated with chronic diseases7, underscoring the importance of studying our ancestral gut microbiome. However, relatively little is known about the composition of pre-industrial gut microbiomes. Here we performed a large-scale de novo assembly of microbial genomes from palaeofaeces. From eight authenticated human palaeofaeces samples (1,000-2,000 years old) with well-preserved DNA from southwestern USA and Mexico, we reconstructed 498 medium- and high-quality microbial genomes. Among the 181 genomes with the strongest evidence of being ancient and of human gut origin, 39% represent previously undescribed species-level genome bins. Tip dating suggests an approximate diversification timeline for the key human symbiont Methanobrevibacter smithii. In comparison to 789 present-day human gut microbiome samples from eight countries, the palaeofaeces samples are more similar to non-industrialized than industrialized human gut microbiomes. Functional profiling of the palaeofaeces samples reveals a markedly lower abundance of antibiotic-resistance and mucin-degrading genes, as well as enrichment of mobile genetic elements relative to industrial gut microbiomes. This study facilitates the discovery and characterization of previously undescribed gut microorganisms from ancient microbiomes and the investigation of the evolutionary history of the human gut microbiota through genome reconstruction from palaeofaeces.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Bacterias / Genoma Bacteriano / Biodiversidad / Evolución Biológica / Heces / Microbioma Gastrointestinal / Interacciones Microbiota-Huesped Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: Mexico Idioma: En Revista: Nature Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Bacterias / Genoma Bacteriano / Biodiversidad / Evolución Biológica / Heces / Microbioma Gastrointestinal / Interacciones Microbiota-Huesped Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: Mexico Idioma: En Revista: Nature Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos